Recent years have seen substantial growth and innovation in the oncology information systems (OIS) market, driven by the rising incidence of cancer and the demand for cutting-edge technologies to assist oncology care. The complicated workflows involved in cancer diagnosis, treatment planning, and follow-up care are managed and streamlined by oncology information systems, which are full software solutions.
OIS adoption has been influenced by a number of variables. First of all, the prevalence of cancer is increasing globally, which has increased the need for effective and integrated systems to manage the expanding amount of patient data, treatment plans, and medical imaging. OIS offers oncologists and other healthcare professionals a centralized platform to store patient data, monitor therapeutic progress, and promote interdisciplinary collaboration.
Second, the capabilities of OIS have been improved by technological developments like image-guided therapy decision support systems, and integration with electronic health records (EHRs). These developments allow for more accurate treatment planning, increased radiation therapy accuracy, and greater care coordination between healthcare professionals.
The introduction of OIS has also been influenced by regulatory restrictions and quality standards for oncology care. Adherence to best practices standardization and quality assurance in cancer therapy are ensured through compliance with regulatory requirements and accreditation agencies.
As the complexity of cancer care continues to increase, and personalized medicine approaches gain prominence, the Oncology Information Systems market is expected to witness further growth and innovation. The integration of artificial intelligence, machine learning, and big data analytics into OIS holds immense potential for improving treatment outcomes, supporting clinical decision-making, and advancing cancer research.
Dynamic and revolutionary developments that are reshaping the sector are what define the Oncology Information Systems (OIS) market. The constant development of technology and the incorporation of artificial intelligence (AI) and machine learning (ML) capabilities are two important market factors. Improved data analysis, treatment planning, and decision assistance are all features of AI-powered OIS solutions, which increase the accuracy and effectiveness of oncology care.
The growing emphasis on targeted medicines and personalized medicine in oncology is another dynamic aspect. In order to support customized treatment regimens and improve patient outcomes, OIS systems are advancing to combine genomic data, molecular profiling, and therapeutic guidelines. By combining genomic data with OIS, oncologists may choose the best treatments for a patient according to their genetic profile, increasing the effectiveness of their treatment.
Additionally, the dynamics of the market are being affected by the increased popularity of cloud-based OIS solutions. Scalability, adaptability, and accessibility of patient data are provided via cloud-based solutions, allowing for seamless provider collaboration as well as remote consultations and second opinions.
The demand for integrated and effective oncology treatment is increasing, and this is projected to drive additional expansion and innovation in the market for oncology information systems. OIS solutions will continue to develop, including new technologies and capabilities to enable personalized, data-driven, and patient-centered cancer care, thanks to the market's dynamism.
As per the report, the global Oncology Information Systems Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
The solutions segment is projected to dominate the intracranial aneurysm market in terms of revenue generation by 2025, primarily due to the growing integration of advanced digital health technologies in neurological care. These solutions encompass comprehensive software platforms that support diagnosis, treatment planning, real-time imaging, and post-treatment monitoring. Hospitals and neurosurgical centers are increasingly investing in end-to-end solutions that combine AI-powered imaging analytics, data integration, and clinical workflow automation to streamline decision-making and enhance patient outcomes. With the rising prevalence of intracranial aneurysms, healthcare providers are prioritizing early detection and risk assessment tools, pushing the demand for scalable and interoperable solutions. Additionally, the demand for cloud-based platforms that ensure seamless data sharing among care teams is gaining traction, especially in tele-neurosurgery and remote diagnostics. Vendors are also focusing on enhancing user interfaces and system security to meet evolving clinical needs and regulatory compliance. As healthcare systems across the globe shift toward value-based care, the ability of these solutions to deliver measurable improvements in outcomes, efficiency, and patient safety positions them as a cornerstone of the modern aneurysm treatment ecosystem.
The radiation oncology segment is projected to experience the fastest growth in the oncology information systems (OIS) market over the forecast period to 2034, driven by the increasing global demand for precision radiotherapy and the rising prevalence of cancers treatable through radiation. As radiation treatments become more technologically advanced—integrating modalities like intensity-modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), and proton therapy—there is a growing need for robust OIS platforms that can manage complex treatment planning, patient data, and image analytics. Moreover, the emphasis on reducing treatment errors, improving patient outcomes, and streamlining workflow in oncology departments has further propelled the adoption of OIS in radiation oncology. Investments in oncology infrastructure across emerging markets and integration with electronic health records (EHR) systems are also catalyzing this segment’s rapid expansion.
By Products & Services
By Application
By End-User
Geographical Analysis
Regional Insights:
*List not Exhaustive
1. Executive Summary
1.1 Introduction to Oncology Information Systems Markets
1.2 Oncology Information Systems Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Oncology Information Systems Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Oncology Information Systems Market Trends
3.2 Key Oncology Information Systems Market Growth Drivers
3.3 Key Oncology Information Systems Market Growth Restraints
4 Oncology Information Systems Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Oncology Information Systems Market Segmentation- Outlook by Type
5.1 Solutions Market Outlook to 2030
5.2 Professional Services Market Outlook to 2030
6. Oncology Information Systems Market Segmentation- Outlook by Application
6.1 Medical Oncology Market Outlook to 2030
6.2 Radiation Oncology Market Outlook to 2030
6.3 Surgical Oncology Market Outlook to 2030
7. Oncology Information Systems Market Segmentation- Outlook by End-Use
7.1 Hospitals & Diagnostic Imaging Centers Market Outlook to 2030
7.2 Ablation Care Centers and Cancer Care Centers Market Outlook to 2030
7.3 Government Institutions Market Outlook to 2030
7.4 Research Facilities Market Outlook to 2030
8. North America Oncology Information Systems Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Oncology Information Systems Market Growth Opportunities
8.3 North America Oncology Information Systems Market Outlook by Application
8.4 North America Oncology Information Systems Market Outlook by Type
8.5 North America Oncology Information Systems Market Outlook by Country
8.6 United States Oncology Information Systems Market Outlook
8.7 Canada Oncology Information Systems Market Outlook
8.8 Mexico Oncology Information Systems Market Outlook
9. Europe Oncology Information Systems Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Oncology Information Systems Market Outlook by Application
9.3 Europe Oncology Information Systems Market Outlook by Type
9.4 Europe Oncology Information Systems Market Outlook by Country
9.5 Germany Oncology Information Systems Market Outlook
9.6 France Oncology Information Systems Market Outlook
9.7 United Kingdom Oncology Information Systems Market Outlook
9.8 Spain Oncology Information Systems Market Outlook
9.9 Italy Oncology Information Systems Market Outlook
9.10 Other Europe Oncology Information Systems Market Outlook
10. Asia Pacific Oncology Information Systems Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Oncology Information Systems Market Outlook by Application
10.3 Asia Pacific Oncology Information Systems Market Outlook by Type
10.4 Asia Pacific Oncology Information Systems Market Outlook by Country
10.5 China Oncology Information Systems Market Outlook
10.6 Japan Oncology Information Systems Market Outlook
10.7 India Oncology Information Systems Market Outlook
10.8 Other Asia Pacific Oncology Information Systems Market Outlook
11. Latin America Oncology Information Systems Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Oncology Information Systems Market Outlook by Application
11.3 Latin America Oncology Information Systems Market Outlook by Type
11.4 Latin America Oncology Information Systems Market Outlook by Country
11.5 Brazil Oncology Information Systems Market Outlook
11.6 Argentina Oncology Information Systems Market Outlook
11.7 Other Latin America Oncology Information Systems Market Outlook
12. Middle East and Africa Oncology Information Systems Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaOncology Information Systems Market Outlook by Application
12.3 Middle East and AfricaOncology Information Systems Market Outlook by Type
12.4 Middle East and AfricaOncology Information Systems Market Outlook by Country
12.5 Saudi Arabia Oncology Information Systems Market Outlook
12.6 UAE Oncology Information Systems Market Outlook
12.7 South Africa Oncology Information Systems Market Outlook
12.8 Other Middle East and Africa Oncology Information Systems Market Outlook
13 Profiles of major Oncology Information Systems Companies
Elekta AB
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Accuray Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Varian Medical Systems, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
RaySearch Laboratories
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Cerner Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Brainlab AG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Philips Healthcare
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Prowess Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
DOSIsoft SA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
ViewRay Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
McKesson Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Siemens Medical Solutions, Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
By Products & Services
By Application
By End-User
Geographical Analysis
The Global Oncology Information Systems Market Size is estimated at $3.2 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.4% to reach $6.6 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Accuray Inc, BrainLab, DOSIsoft SA, Elekta, FLATIRON HEALTH, Koninklijke Philips N.V., Oracle, RaySearch Laboratories, Varian Medical Systems, Inc, and Others.
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume